Author
Listed:
- Simon Raffel
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance
Heidelberg University Hospital)
- Mattia Falcone
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance)
- Niclas Kneisel
(German Cancer Research Center (DKFZ))
- Jenny Hansson
(European Molecular Biology Laboratory (EMBL))
- Wei Wang
(German Cancer Research Center (DKFZ))
- Christoph Lutz
(Heidelberg University Hospital)
- Lars Bullinger
(University Hospital Ulm)
- Gernot Poschet
(University of Heidelberg)
- Yannic Nonnenmacher
(Technical University Braunschweig
University of Luxemburg)
- Andrea Barnert
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance)
- Carsten Bahr
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance)
- Petra Zeisberger
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance)
- Adriana Przybylla
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance)
- Markus Sohn
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance)
- Martje Tönjes
(German Cancer Research Center (DKFZ))
- Ayelet Erez
(Weizmann Institute of Science)
- Lital Adler
(Weizmann Institute of Science)
- Patrizia Jensen
(National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ))
- Claudia Scholl
(German Cancer Research Center (DKFZ)
German Cancer Consortium (DKTK), DKFZ)
- Stefan Fröhling
(National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Heidelberg University Hospital
German Cancer Consortium (DKTK), DKFZ)
- Sibylle Cocciardi
(University Hospital Ulm)
- Patrick Wuchter
(Heidelberg University Hospital
Institute of Transfusion Medicine and Immunology Mannheim, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen)
- Christian Thiede
(University Hospital Carl Gustav Carus)
- Anne Flörcken
(Oncology and Tumor Immunology; Charité-University Medicine Berlin, Campus Virchow Klinikum)
- Jörg Westermann
(Oncology and Tumor Immunology; Charité-University Medicine Berlin, Campus Virchow Klinikum)
- Gerhard Ehninger
(University Hospital Carl Gustav Carus)
- Peter Lichter
(German Cancer Research Center (DKFZ)
German Cancer Consortium (DKTK), DKFZ)
- Karsten Hiller
(Technical University Braunschweig
University of Luxemburg)
- Rüdiger Hell
(University of Heidelberg)
- Carl Herrmann
(German Cancer Research Center (DKFZ)
University of Heidelberg)
- Anthony D. Ho
(Heidelberg University Hospital)
- Jeroen Krijgsveld
(European Molecular Biology Laboratory (EMBL))
- Bernhard Radlwimmer
(German Cancer Research Center (DKFZ)
German Cancer Consortium (DKTK), DKFZ)
- Andreas Trumpp
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance
German Cancer Consortium (DKTK), DKFZ)
Abstract
In Extended Data Fig. 1a of this Letter, the flow cytometry plot depicting the surface phenotype of AML sample DD08 was a duplicate of the plot for AML sample DD06. Supplementary Data 4 has been added to the Supplementary Information of the original Letter to clarify the proteome data acquisition and presentation. The original Letter has been corrected online.
Suggested Citation
Simon Raffel & Mattia Falcone & Niclas Kneisel & Jenny Hansson & Wei Wang & Christoph Lutz & Lars Bullinger & Gernot Poschet & Yannic Nonnenmacher & Andrea Barnert & Carsten Bahr & Petra Zeisberger & , 2018.
"Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation,"
Nature, Nature, vol. 560(7718), pages 28-28, August.
Handle:
RePEc:nat:nature:v:560:y:2018:i:7718:d:10.1038_s41586-018-0403-9
DOI: 10.1038/s41586-018-0403-9
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:560:y:2018:i:7718:d:10.1038_s41586-018-0403-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.